Rimidi Diabetes


Diabetes is a rapidly growing disease; for many patients, especially those who may not have reliable access to quality healthcare, the disease is currently mismanaged. Rimidi Diabetes has developed a software solution focused on safely managing blood glucose, which allows patients and physicians to identify and close gaps in diabetes management. The company’s product has been shown to increase patient adherence to medical advice from fifty to ninety percent. They participated in the Village Capital-VentureWell HEALTH Boston Accelerator in 2014. VentureWell invested in November 2014. Co-investors include Investors’ Circle, Village Capital, Hitachi, Cox Enterprises, and The JumpFund.

By continuing to use the site, you agree to the use of cookies. Read More